Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coya Therapeutics (COYA) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to $317066.0.

  • Coya Therapeutics' Non Operating Income fell 2606.96% to $317066.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 521.56%. This contributed to the annual value of $1.6 million for FY2024, which is 15785.54% up from last year.
  • According to the latest figures from Q3 2025, Coya Therapeutics' Non Operating Income is $317066.0, which was down 2606.96% from $319541.0 recorded in Q2 2025.
  • Coya Therapeutics' Non Operating Income's 5-year high stood at $444232.0 during Q4 2024, with a 5-year trough of $142089.0 in Q3 2023.
  • Over the past 3 years, Coya Therapeutics' median Non Operating Income value was $319541.0 (recorded in 2025), while the average stood at $299524.9.
  • In the last 5 years, Coya Therapeutics' Non Operating Income skyrocketed by 20183.27% in 2024 and then tumbled by 2606.96% in 2025.
  • Coya Therapeutics' Non Operating Income (Quarter) stood at $174672.0 in 2023, then skyrocketed by 154.32% to $444232.0 in 2024, then fell by 28.63% to $317066.0 in 2025.
  • Its last three reported values are $317066.0 in Q3 2025, $319541.0 for Q2 2025, and $370165.0 during Q1 2025.